LIVE: AstraZeneca Admits Covishield Clot Risks. Should you be Worried? | Vantage with Palki Sharma
LIVE: AstraZeneca Admits Covishield Clot Risks. Should you be Worried? | Vantage with Palki Sharma
AstraZeneca, the British Pharma company has admitted that its COVID-19 vaccine, Covishield, can cause rare side effects, including serious blood clotting. This comes after dozens of lawsuits were filed in a UK court alleging that the vaccine is defective and has caused serious injury and death. While AstraZeneca denies these claims, the acknowledgement has sparked controversy on various social media platforms with users questioning the Indian government's approval process for AstraZeneca's jab. What's the controversy? And should you be worried? On Vantage tonight, Palki Sharma brings you the full story.
---
AstraZeneca | Covishield | COVID 19 | Vaccine | UK | Firstpost | World News | News Live | Vantage | Palki Sharma | News
#astrazeneca #covishield #covid19 #vaccine #uk #firstpost #vantageonfirstpost #palkisharma #worldnews
Vantage is a ground-breaking news, opinions, and current affairs show from Firstpost. Catering to a global audience, Vantage covers the biggest news stories from a 360-degree perspective, giving viewers a chance to assess the impact of world events through a uniquely Indian lens.
The show is anchored by Palki Sharma, Managing Editor, Firstpost.
By breaking stereotypes, Vantage aims to challenge conventional wisdom and present an alternative view on global affairs, defying the norm and opening the door to new perspectives. The show goes beyond the headlines to uncover the hidden stories – making Vantage a destination for thought-provoking ideas.
Vantage airs Monday to Friday at 9 PM IST on Firstpost across all leading platforms.
Subscribe to Firstpost channel and press the bell icon to get notified when we go live.
https://www.youtube.com/@Firstpost
Follow Firstpost on Instagram:
https://www.instagram.com/firstpost/
Follow Firstpost on Facebook:
https://www.facebook.com/firstpostin/
Follow Firstpost on Twitter:
https://twitter.com/firstpost
Follow Firstpost on WhatsApp:
https://www.whatsapp.com/channel/0029Va6zOIrEQIamseyg762V
n18_live_dl
AstraZeneca, the British Pharma company has admitted that its COVID-19 vaccine, Covishield, can cause rare side effects, including serious blood clotting. This comes after dozens of lawsuits were filed in a UK court alleging that the vaccine is defective and has caused serious injury and death. While AstraZeneca denies these claims, the acknowledgement has sparked controversy on various social media platforms with users questioning the Indian government's approval process for AstraZeneca's jab. What's the controversy? And should you be worried? On Vantage tonight, Palki Sharma brings you the full story.
---
AstraZeneca | Covishield | COVID 19 | Vaccine | UK | Firstpost | World News | News Live | Vantage | Palki Sharma | News
#astrazeneca #covishield #covid19 #vaccine #uk #firstpost #vantageonfirstpost #palkisharma #worldnews
Vantage is a ground-breaking news, opinions, and current affairs show from Firstpost. Catering to a global audience, Vantage covers the biggest news stories from a 360-degree perspective, giving viewers a chance to assess the impact of world events through a uniquely Indian lens.
The show is anchored by Palki Sharma, Managing Editor, Firstpost.
By breaking stereotypes, Vantage aims to challenge conventional wisdom and present an alternative view on global affairs, defying the norm and opening the door to new perspectives. The show goes beyond the headlines to uncover the hidden stories – making Vantage a destination for thought-provoking ideas.
Vantage airs Monday to Friday at 9 PM IST on Firstpost across all leading platforms.
Subscribe to Firstpost channel and press the bell icon to get notified when we go live.
https://www.youtube.com/@Firstpost
Follow Firstpost on Instagram:
https://www.instagram.com/firstpost/
Follow Firstpost on Facebook:
https://www.facebook.com/firstpostin/
Follow Firstpost on Twitter:
https://twitter.com/firstpost
Follow Firstpost on WhatsApp:
https://www.whatsapp.com/channel/0029Va6zOIrEQIamseyg762V
n18_live_dl
